According to a new market research report titled, ‘Microbubbles/Ultrasound Contrast Agents Market by Application
(Diagnostic Imaging [Cardiovascular, Renal, Abdominal, Breast] Therapeutics)
Type (Lipid, Protein, Polymer) End User (Hospitals & Clinics, Diagnostics
Laboratories)- Global Forecast to 2030,’ published by Meticulous Research®,
the microbubbles/ultrasound contrast agents market is projected to reach $1.95
billion by 2030, at a CAGR of 15.2% from 2023 to 2030.
Ultrasound contrast agents are gas-filled microbubbles that are used to
improve the capabilities of diagnostic imaging. They play an important role in
ultrasound imaging and ultrasound-mediated therapy. Microbubble contrast agents
are giving new avenues for therapeutic applications of ultrasound in drug
delivery, gene therapy, and thrombolysis.
Download Free Sample Report Now: https://www.meticulousresearch.com/download-sample-report/cp_id=3732
The report also includes an extensive assessment of the key strategic
developments of leading market participants in the industry in the last three
to four years. The global microbubbles/ultrasound contrast agents’ market has
witnessed several strategic developments in recent years.
The high demand for image & diagnostics-guided procedures, the
growing aging population, coupled with the rising prevalence of chronic
diseases, technological advances in ultrasound imaging, and favourable
reimbursement policies for contrast-enhanced procedures are driving the growth
of this market. In addition, increasing microbubbles/ultrasound contrast
agents-related research activities will likely offer better opportunities for
market growth. However, the complexity involved in contrast-enhanced Ultrasound
(CEUS) is expected to restrain the market's growth to some extent.
Aging Population Coupled with the Increasing Prevalence of Chronic
Diseases to Drive the Demand for Microbubbles/Ultrasound Contrast Agents
Chronic diseases such as cardiovascular diseases, osteoarticular
problems, sleep and mobility disorders, diabetes, and chronic ischemic heart
disease is a major and common concern among the elderly population. They can
lead to limitations in mental and physical abilities, hospitalization, and
increased healthcare expenditures.
Osteoporosis is a common condition in the elderly population that can be
detected using ultrasound. However, chronic diseases such as diabetes and
cardiovascular disease can also affect bone health and may lead to
false-positive results on ultrasound. Thus, it is important to consider the
presence of chronic diseases in the elderly population when interpreting the
ultrasound results.
Have Any Query? Ask To Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=3732
According to the World Population Ageing 2020 report released by the
Department of Economic and Social Affairs, United Nations, globally, there were
727 million people aged 65 or above in 2020. It is estimated that by 2050 this
number will reach 1.5 billion.
The aging population drives a rise in the number of people suffering
from chronic diseases. Having an ultrasound near the bed is incredibly useful
to older people who cannot move easily or may be anxious to travel to another
setting. This increases the demand for ultrasound procedures for older adults.
Ultrasound technology can be used for evaluating several disorders, such as
bone health and diagnosing heart disease, which may lead to an increased demand
for ultrasound in the geriatric population.
Hence, the aging population will likely increase the demand for
microbubbles/ultrasound contrast agents due to growing utilization, the rising
prevalence of chronic diseases, and the increased demand for healthcare
services.
Microbubbles/Ultrasound Contrast Agents Market: Future Outlook
The microbubbles/ultrasound contrast agents market is segmented by type
[lipid microbubbles, protein microbubbles, polymer microbubbles], application
[diagnostics imaging {cardiovascular imaging, renal imaging, abdominal imaging,
breast imaging, other diagnostics imaging applications}, therapeutic
applications], end user (hospitals & clinics, diagnostics laboratories,
other end users], and geography (North America, Europe, Asia-Pacific, Latin
America, and Middle East & Africa).
Based on type, the microbubbles/ultrasound contrast agents’ market is
segmented into lipid microbubbles, protein microbubbles, and polymer
microbubbles. The lipid microbubbles segment is expected to account for the
largest share of the market in 2023. Lipid-based microbubbles ultrasound
imaging with contrast agents has become an essential tool in clinical
diagnostics. It is applied in drug delivery systems which are the materials
working for soft synthetic shells. These lipid shells offer several ways to support
additional functions over increased contrast, such as minimally invasive
detection of biochemical signatures. Additionally, improved ultrasound imaging
technology and safety & security support the largest share of the segment.
Quick Buy – Microbubbles/Ultrasound Contrast Market- Global
Opportunity Analysis and Industry Forecast (2023-2030), Research Report: https://www.meticulousresearch.com/Checkout/23012734
Based on application, the microbubbles/ultrasound contrast agents market
is segmented into diagnostics imaging and therapeutic applications. Diagnostic
imaging is expected to account for the largest share of the
microbubbles/ultrasound contrast agents market in 2023. The large market share
of this segment is attributed to the technological developments in specialized
application modalities, increasing awareness among people regarding early
diagnosis, and the rising prevalence of chronic diseases, including cardiovascular
diseases such as heart failure and coronary artery disease are the major causes
of premature death every year. For instance, according to the Centers for
Disease Control and Prevention, in 2020, about 523 million people had some form
of cardiovascular disease and nearly 19 million deaths were caused globally.
Based on end user, in 2023, the hospitals & clinics segment is
expected to account for the largest share of the microbubbles/ultrasound
contrast agents market. People prefer visiting hospitals for treatment as
hospitals or clinics have well-established infrastructure. Most people regained
the accessibility of healthcare facilities and started visiting hospitals for
routine checkups or testing, contributing to the large market share of the
segment.
Based on geography, the microbubbles/ultrasound contrast agents market
is segmented into North America, Europe, Asia-pacific, Latin America, and
Middle East & Africa. In 2023, North America is expected to account for the
largest share of the microbubbles/ultrasound contrast agents market. The large
market share of this segment is primarily due to the aging population and
increasing prevalence of chronic diseases, advanced healthcare systems in the
U.S. and Canada, accelerated growth of economies and high adoption of advanced
technologies.
Some of the key players operating in the microbubbles/ultrasound
contrast agents market are Lantheus Holdings, Inc. (U.S.), GE
HealthCare Technologies Inc. (U.S.), Bracco S.p.A. (Italy), Bristol-Myers
Squibb Company (U.S.), Daiichi Sankyo Company, Limited (Japan), nanoPET Pharma
GmbH (Germany), Leriva (Greece), Siemens Healthineers AG (Germany), Bayer AG
(Germany), and Fujifilm Holdings Corporation (Japan).
To gain more insights into the market with a detailed table of content
and figures, click here: https://www.meticulousresearch.com/product/microbubbles-ultrasound-contrast-agents-market-3732
Scope of the Report:
Microbubbles/Ultrasound Contrast Agents Market Assessment - by Type
- Lipid Microbubbles
- Protein Microbubbles
- Polymer Microbubbles
Microbubbles/Ultrasound Contrast Agents Market Assessment - by
Application
- Diagnostics Imaging
- Cardiovascular Imaging
- Renal Imaging
- Abdominal Imaging
- Breast Imaging
- Other Diagnostics
Imaging Applications
- Therapeutics
Applications
(Note: Other diagnostics imaging applications include cancer and ocular)
Request Free Sample Report Now: https://www.meticulousresearch.com/request-sample-report/cp_id=3732
Microbubbles/Ultrasound Contrast Agents Market Assessment - by End User
- Hospitals & Clinics
- Diagnostics
Laboratories
- Other End Users
(Note: Other end users include pharmaceutical & biotech companies,
research & academic institutes, and government laboratories)
Microbubbles/Ultrasound Contrast Agents Market Assessment- by Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East &
Africa
TOP 10 COMPANIES IN MICROBUBBLES/ULTRASOUND CONTRAST AGENTS MARKET
@ https://meticulousblog.org/top-10-companies-in-microbubbles-ultrasound-contrast-agents-market/?utm_source=article&utm_medium=social&utm_campaign=product&utm_content=07-11-2023
No comments:
Post a Comment